USA Rare Earth Bets €175M on Europe as the West’s Critical Materials Race Enters a New Phase

USA Rare Earth, Inc. (NASDAQ: USAR) announced on June 1, 2026, that it plans to invest more than €175 million in rare earth metal, alloy, and magnet manufacturing in France through 2030 — a move that cements the company's ambition to become the primary transatlantic supplier of critical materials for aerospace, defense, electric vehicles, and physical AI infrastructure.

Shares closed Friday at $28.01, off a modest 0.64% on the session, but the stock remains near its recent highs after surging 16.1% over the past week and 23.8% over the past month. Year-to-date, USAR has nearly doubled, up 99.2% — significantly outpacing the broader materials sector.

What USAR Is Building in France

The expansion builds directly on USAR's existing French infrastructure:

• Less Common Metals (LCM) — a rare earth metal and alloy production facility at Lacq, France, which USAR already operates
• Carester SAS — USAR's strategic stake in France's rare earth magnet manufacturer
• Job creation — the program is projected to add more than 300 jobs to the Lacq industrial cluster
• Government backing — the capital program is structured to leverage France's C3IV green industry tax credit, alongside potential state-backed debt guarantees and direct equity investment into USAR's European subsidiary

The strategic logic is straightforward: France's C3IV programme is one of the most generous industrial incentive structures in Europe for critical materials, and USAR is positioning itself to capture a substantial portion of it while simultaneously locking in processing capacity ahead of anticipated demand from European EV manufacturers and defense contractors.

Why This Matters Beyond the Headline Number

The France announcement does not stand alone. It layers onto an accelerating series of capital milestones that together suggest USAR has moved from a speculative mining story to a credible integrated rare earth platform:

$1.6 billion in proposed U.S. federal support — In January 2026, USAR signed a non-binding Letter of Intent with the U.S. Department of Commerce outlining $277 million in proposed CHIPS Act grant funding and a $1.3 billion senior secured loan. That framework has not yet converted to binding commitments, but its scale signals the degree of government interest in USAR's domestic processing buildout.

$19.3 million DOE award — Eleven days before today's France announcement, USAR was selected for up to $19.3 million in Department of Energy funding under the Critical Materials Innovation Program, supporting a $50.5 million pilot-scale rare earth separation facility.

$2.8 billion Serra Verde acquisition — USAR's acquisition of Brazilian rare earth miner Serra Verde added meaningful proven reserves and positioned the company further up the supply chain, though it also added execution complexity.

Taken together, USAR is simultaneously building out upstream supply (Serra Verde), domestic processing (DOE programme), and European downstream manufacturing (Lacq / Carester). That is an ambitious multi-jurisdictional buildout for a company still pre-profitability.

The Bull Case and the Risks

Wall Street's sell-side has turned decisively positive. The consensus sits at a unanimous Strong Buy among covering analysts, with a consensus price target of $34.25 — implying roughly 22% upside from Friday's close. The target distribution is tight: $32.00 at the low end, $35.00 from Wedbush, Cantor Fitzgerald, and Roth Capital, and an outlier high of $47.25.

Recent target upgrades reflect improving visibility on the federal financing pipeline:

• Wedbush (S. Brandeis) — Outperform, target raised to $35.00 from $29.00 (May 14)
• Cantor Fitzgerald (D. Soderberg) — Overweight, target raised to $35.00 from $30.00 (May 14)
• Canaccord Genuity — Buy, target raised to $32.00 from $29.00 (late April)
• Roth Capital — Buy, $35.00 target (reiterated)

The valuation picture, however, reflects the pre-revenue reality. USAR trades at a forward P/E of negative 85.96x. Consensus models project quarterly revenue scaling from roughly $6 million in Q2 2026 to $21 million by Q4 2026, reaching an annualised run-rate of $148 million by end-2027 and $399 million by 2028. EPS is not expected to turn positive until 2028 at $0.91 per share.

Investor Takeaway

The France expansion is the clearest signal yet that USAR is executing on a genuinely transatlantic strategy rather than a purely domestic one. The combination of French government incentives, existing LCM infrastructure, and the Carester stake gives this announcement more credibility than a greenfield commitment would. At the same time, investors should weigh the execution complexity: USAR is simultaneously integrating a $2.8 billion acquisition, managing multi-jurisdictional regulatory relationships, and deploying capital across three continents — all while operating at a loss.

For investors already in the stock after a near-doubling year-to-date, the France announcement extends the narrative runway without materially changing the near-term financial picture. For those considering entry, the $34.25 consensus target offers a defined upside case, but the path to realising it runs through a multi-year capital deployment programme with significant execution risk at every stage.